Key result
Early-onset insulin-treated diabetes is linked to higher mortality, driven by metabolic complications then CVD.
Cohort (n=23,752)
Yes
Answers are grounded in this paper and cite their sources.
Summary Aims To measure cause‐specific mortality, by age, in patients with insulin‐treated diabetes incident at a young age. Methods A cohort of 23 752 patients with insulin‐treated diabetes diagnosed under the age of 30 years, from throughout the United Kingdom, was identified during 1972–93 and followed to February 1997. Death certificates have been obtained for deaths during the follow‐up period and cause‐specific mortality rates and standardized mortality ratios by age and sex are reported. Results During the follow‐up period 949 deaths occurred and at all ages mortality rates were considerably higher than in the general population. Acute metabolic complications of diabetes were the greatest single cause of excess death under the age of 30 years. Cardiovascular disease was responsible for the greatest proportion of the deaths from the age of 30 years onwards. Conclusions Deaths in patients with diabetes diagnosed under the age of 30 have been reported and comparisons drawn with mortality in the general population. To reduce these deaths attention must be paid both to the prevention of acute metabolic deaths and the early detection and treatment of cardiovascular disease and associated risk factors.
No takes yet. Share an insight, caveat, or question.
Laing et al. (1999) conducted a cohort in Insulin-treated diabetes mellitus (n=23,752). Insulin-treated diabetes mellitus diagnosed under age 30 vs. General population was evaluated on Cause-specific mortality. Insulin-treated diabetes diagnosed under age 30 was associated with 949 deaths and higher mortality than the general population, driven by metabolic complications (<30 y) and CVD (≥30 y).
Synapse has enriched 10 related papers. Consider them for comparative context: